CARsgen Therapeutics Holdings Limited (2171.HK)
HKD 15.94
(2.57%)
HKD 15.94
(2.57%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 85.22 Million CNY | -28.65% |
| 2022 | 119.44 Million CNY | -64.67% |
| 2021 | 338.04 Million CNY | 237.18% |
| 2020 | 100.25 Million CNY | 18.89% |
| 2019 | 84.32 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 129.11 Million CNY | 65.02% |
| 2024 Q1 | 129.11 Million CNY | 51.51% |
| 2023 Q4 | 85.22 Million CNY | 16.76% |
| 2023 FY | 85.22 Million CNY | -28.65% |
| 2023 Q3 | 72.99 Million CNY | -34.3% |
| 2023 Q2 | 111.08 Million CNY | 17.11% |
| 2023 Q1 | 94.85 Million CNY | -20.58% |
| 2022 Q2 | 343.93 Million CNY | 4.86% |
| 2022 Q1 | 327.98 Million CNY | -2.98% |
| 2022 FY | 119.44 Million CNY | -64.67% |
| 2022 Q4 | 119.44 Million CNY | 16.75% |
| 2022 Q3 | 102.31 Million CNY | -70.25% |
| 2021 FY | 338.04 Million CNY | 237.18% |
| 2021 Q4 | 338.04 Million CNY | 4.33% |
| 2021 Q3 | 324.01 Million CNY | 7.82% |
| 2021 Q2 | 300.5 Million CNY | 3.97% |
| 2021 Q1 | 289.04 Million CNY | 188.3% |
| 2020 FY | 100.25 Million CNY | 18.89% |
| 2020 Q4 | 100.25 Million CNY | 6.24% |
| 2020 Q3 | 94.36 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | 84.32 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -61.197% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 98.563% |